Unit­ed­Health­care CEO Bri­an Thomp­son was shot and killed in Mid­town Man­hat­tan Wednes­day morn­ing ahead of the ...

The market for first-generation weight loss treatments has been dominated by two major players, Eli Lilly and Novo Nordisk.

GSK partners with Duality Biologics in a $30 million upfront deal, potentially worth $975 million, for access to a ...

Versant is out with its third obesity biotech of the year, leading an €80 million Series A for Antag Therapeutics, a Danish ...

Eli Lilly has removed the commonly used clinical measure of body mass index from the FDA label for its weight loss drug ...

GSK has axed a Phase 2 study of a chronic hepatitis B therapeutic vaccine, adding to a string of treatment R&D hurdles for the liver infection.

The SEC said Tuesday that it settled charges filed against Kiromic Biopharma, a tiny immuno-oncology startup based in Texas, ...

In response to lawmakers' concerns, Pfizer and Eli Lilly said last week that they do not influence telehealth partners and ...

Coherus BioSciences' stock surged on Tuesday after the company announced plans to sell off the last biosimilar in its ...

Ipsen has inked yet another licensing deal in an effort to bolster its cancer pipeline, this time for a preclinical T cell ...

Cartesian Therapeutics reported longer-term results from a mid-stage study of its mRNA CAR-T therapy for myasthenia gravis, ...

Bristol Myers Squibb partners with AI Proteins for miniprotein development, with up to $400M in milestones. Terns Pharmaceuticals reports positive Phase 1 data for TERN-701. Six biotechs seek Hong ...